Artia Global Partners »

Mereo Biopharma Group Plc ads shares owned by Artia Global Partners

Quarter-by-quarter ownership of Mereo Biopharma Group Plc ads (MREO) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Mereo Biopharma Group Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Mereo Biopharma Group Plc ads held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mereo Biopharma Group Plc ads by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.7M 421k 4.11
2024-06-30 $1.5M 421k 3.60
2024-03-31 $1.4M 421k 3.30

More positions owned by Artia Global Partners

Eli Lilly & Co. (LLY)
Novo-nordisk A S Adr (NVO)
Viking Therapeutics (VKTX)
Intra Cellular Therapies (ITCI)
Astrazeneca Sponsored Adr (AZN)
Soleno Therapeutics (SLNO)
Alnylam Pharmaceuticals (ALNY)
Vertex Pharmaceuticals Incorporated (VRTX)
Vaxcyte (PCVX)
Argenx Se Sponsored Adr (ARGX)
Axsome Therapeutics (AXSM)
Protagonist Therapeutics (PTGX)
Neurocrine Biosciences (NBIX)
Revolution Medicines (RVMD)
Dyne Therapeutics (DYN)

View all positions for Artia Global Partners

Top funds holding Mereo Biopharma Group Plc ads

Rubric Capital Management
Rock Springs Capital Management
Henderson Group
Deerfield Management Company
Frazier Life Sciences Management
683 Capital Management
Clearline Capital
Tejara Capital
Goldman Sachs Group
Renaissance Technologies
Soleus Capital Management
Marshall Wace
Blue Owl Capital Holdings
NEOS Investment Management
Perceptive Advisors

View all funds holding Mereo Biopharma Group Plc ads